InvestorsHub Logo
Followers 60
Posts 7407
Boards Moderated 0
Alias Born 10/20/2014

Re: JRoon71 post# 394836

Friday, 12/02/2022 2:09:01 PM

Friday, December 02, 2022 2:09:01 PM

Post# of 427053
JRoon71, With positive BRAVE results, that would be an incentive for CVD
patients in "protected jurisdictions" to go out of their way to be prescribed
Vascepa. Of course, CVD is linked to AD, so for the reasons I mentioned
it is not a stretch to believe Vascepa would help with both indications. Maybe
BP would be more proactive (should the BRAVE study show efficacy) than
AMRN in GIA mode, to get the word out to doctors who would understand
the logic. Such a great drug that Vascepa could have been.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News